F. Curreli

发表

Transcriptional Downregulation of ORF50/Rta by Methotrexate Inhibits the Switch of Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 from Latency to Lytic Replication

E. Cesarman, F. Curreli, F. Cerimele, 2002, Journal of Virology.

Antiviral activity of α-helical stapled peptides designed from the HIV-1 capsid dimerization domain

A. Debnath, D. Cowburn, E. Freed, 2011, Retrovirology.

Design, synthesis, and antiviral activity of a series of CD4-mimetic small-molecule HIV-1 entry inhibitors.

A. Debnath, A. Altieri, F. Curreli, 2021, Bioorganic & medicinal chemistry.

Synthesis, Antiviral Activity, and Structure–Activity Relationship of 1,3‐Benzodioxolyl Pyrrole‐Based Entry Inhibitors Targeting the Phe43 Cavity in HIV‐1 gp120

A. Debnath, A. Altieri, F. Curreli, 2018, ChemMedChem.

Design, synthesis and evaluation of small molecule CD4-mimics as entry inhibitors possessing broad spectrum anti-HIV-1 activity.

A. Debnath, A. Altieri, F. Curreli, 2016, Bioorganic & medicinal chemistry.

Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor.

A. Debnath, F. Curreli, Jinfeng Xu, 2015, Bioorganic & medicinal chemistry.

Design of antiviral stapled peptides containing a biphenyl cross-linker.

A. Debnath, Nan Li, Qing Lin, 2014, Bioorganic & medicinal chemistry letters.

HIV-1 gp120 Antagonists Also Inhibit HIV-1 Reverse Transcriptase by Bridging the NNRTI and NRTI Sites.

A. Debnath, E. Arnold, K. Das, 2021, Journal of medicinal chemistry.

Guanidine‐Containing Phenyl‐Pyrrole Compounds as Probes for Generating HIV Entry Inhibitors Targeted to gp120

A. Debnath, A. Altieri, F. Curreli, 2018, ChemistrySelect.

Synthesis of 5-Arylpyrrole-2-carboxylic Acids as Key Intermediates for NBD Series HIV-1 Entry Inhibitors

A. Debnath, A. Altieri, F. Curreli, 2017 .

α-Helix-Mimetic Foldamers for Targeting HIV-1 TAR RNA.

A. Debnath, A. Hamilton, Sunil Kumar, 2019, Chemistry.

Detection and quantitation of Kaposi's sarcoma-associated herpesvirus (KSHV) by a single competitive-quantitative polymerase chain reaction.

F. Curreli, A. Friedman-kien, O. Flore, 2003, Journal of virological methods.

Glycyrrhizic acid alters Kaposi sarcoma-associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes.

F. Curreli, A. Friedman-kien, O. Flore, 2005, The Journal of clinical investigation.

Identification of Combinations of Protein Kinase C Activators and Histone Deacetylase Inhibitors that Potently Reactivate Latent HIV

A. Debnath, F. Curreli, Shahad Ahmed, 2020, Viruses.

ENHANCING THE URBAN QUALITY OF LIFE: A CASE STUDY OF A COASTAL CITY IN THE METROPOLITAN AREA OF ROME

F. Cumo, G. Piras, F. Curreli, 2017 .

Antiviral Activity and Crystal Structures of HIV-1 gp120 Antagonists

A. Debnath, P. Kwong, Y. Kwon, 2022, International journal of molecular sciences.

Comparative Pharmacokinetics of a Dual Inhibitor of HIV-1, NBD-14189, in Rats and Dogs with a Proof-of-Concept Evaluation of Antiviral Potency in SCID-hu Mouse Model

A. Debnath, S. Horrigan, C. Stoddart, 2022, Viruses.

Targeting HIV‐TB coinfection by developing novel piperidin‐4‐substituted imines: Design, synthesis, in vitro and in silico studies

A. Debnath, D. Sriram, K. Pai, 2019, Archiv der Pharmazie.

Kaposi's Sarcoma-Associated Herpesvirus Can Productively Infect Primary Human Keratinocytes and Alter Their Growth Properties

E. Cesarman, S. Ely, F. Curreli, 2001, Journal of Virology.

Dual-acting stapled peptides target both HIV-1 entry and assembly

A. Debnath, M. Summers, E. Freed, 2013, Retrovirology.

A cell-penetrating helical peptide as a potential HIV-1 inhibitor.

A. Debnath, D. Cowburn, E. Freed, 2008, Journal of molecular biology.

Liver regeneration in response to partial hepatectomy in rats treated with retrorsine: a kinetic study.

E. Laconi, D. Sarma, F. Curreli, 1999, Journal of hepatology.

Direct hyperplasia does not enhance the kinetics of liver repopulation in a new model of hepatocyte transplantation in the rat.

E. Laconi, D. Shafritz, S. Pillai, 1999, Journal of hepatology.

Preclinical optimization of gp120 entry-antagonists as anti-HIV-1 agents with improved cytotoxicity and ADME properties through rational design, synthesis, and antiviral evaluation.

A. Debnath, A. Altieri, F. Curreli, 2020, Journal of medicinal chemistry.

Correction to Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120.

A. Debnath, P. Kwong, Y. Kwon, 2017, Journal of medicinal chemistry.

Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120.

Young Do Kwon, Asim K Debnath, Peter D Kwong, 2017, Journal of medicinal chemistry.

Structure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 Activity.

Young Do Kwon, Hongtao Zhang, Asim K Debnath, 2015, Journal of medicinal chemistry.

Early exposure to restraint stress enhances chemical carcinogenesis in rat liver.

M. Collu, G. Serra, E. Laconi, 2000, Cancer letters.

Antiviral Activity of Dual-acting Hydrocarbon-stapled Peptides against HIV-1 Predominantly Circulating in China.

A. Debnath, K. Hong, Shibo Jiang, 2017, Biomedical and environmental sciences : BES.

Discovery of Highly Potent Small Molecule Pan-Coronavirus Fusion Inhibitors

A. Debnath, C. Hillyer, F. Curreli, 2023, bioRxiv.

Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro

A. Debnath, C. Hillyer, A. Drelich, 2020, bioRxiv.

Design, synthesis, and antiviral activity of entry inhibitors that target the CD4-binding site of HIV-1.

A. Debnath, P. Kwong, Y. Kwon, 2012, Journal of medicinal chemistry.

Dual-acting stapled peptides target both HIV-1 entry and assembly

A. Debnath, M. Summers, E. Freed, 2013, Retrovirology.

Discovery of highly potent pancoronavirus fusion inhibitors that also effectively inhibit COVID-19 variants from the UK (Alpha), South Africa (Beta), and India (Delta)

A. Debnath, C. Hillyer, A. Drelich, 2021, bioRxiv.

Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays

A. Debnath, C. Hillyer, A. Drelich, 2021, Viruses.

Structure-based lead optimization to improve antiviral potency and ADMET properties of phenyl-1H-pyrrole-carboxamide entry inhibitors targeted to HIV-1 gp120.

A. Debnath, L. Iyer, Y. Kwon, 2018, European journal of medicinal chemistry.

Binding Mode Characterization of NBD Series CD4-Mimetic HIV-1 Entry Inhibitors by X-Ray Structure and Resistance Study

A. Debnath, P. Kwong, Yongping Yang, 2014, Antimicrobial Agents and Chemotherapy.

Virtual screening based identification of novel small-molecule inhibitors targeted to the HIV-1 capsid.

Hongtao Zhang, Ilya Pyatkin, Asim K Debnath, 2011, Bioorganic & medicinal chemistry.

IN VITRO INFECTION OF PRIMARY HUMAN KERATINOCYTES BY KAPOSI'S SARCOMA ASSOCIATED HERPESVIRUS.

E. Cesarman, D. Knowles, E. Hyjek, 1999 .

Structure-based lead optimization to improve antiviral potency and ADMET properties of phenyl-1H-pyrrole-carboxamide entry inhibitors targeted to HIV-1 gp120.

A. Debnath, L. Iyer, Y. Kwon, 2018, European journal of medicinal chemistry.